Methylmalonic Acid (MMA)
The laboratory test that verifies B12 isn't falsely elevated is serum methylmalonic acid (MMA). 1
Why MMA is the Confirmatory Test
MMA serves as a functional marker of vitamin B12 status rather than simply measuring the vitamin's abundance in serum. When B12 is truly deficient at the cellular level, methylmalonyl-CoA mutase cannot adequately convert methylmalonyl-CoA to succinyl-CoA, leading to accumulation and hydrolysis of excess methylmalonyl-CoA into methylmalonic acid 2.
Clinical Context for False Elevation
Total B12 (serum cobalamin) can be falsely elevated in several scenarios:
- Myeloproliferative disorders: Despite high serum B12 levels, 69% of patients had true B12 deficiency when assessed by MMA 3
- Presence of anti-intrinsic factor antibodies or heterophilic antibodies that interfere with immunoassays 4
- Measurement of biologically inactive haptocorrin-bound B12 rather than the metabolically active holotranscobalamin 2
When to Order MMA
According to 2024 NICE guidelines, consider measuring serum MMA when initial B12 test results fall in the indeterminate range 1:
- Total B12: 180-350 ng/L (133-258 pmol/L)
- Active B12 (holotranscobalamin): 25-70 pmol/L
MMA provides the most reliable diagnosis reflecting functional B12 status, though it's unsuitable as first-line testing due to cost (£11-80 per test) and requirement for specialized equipment 1.
Diagnostic Performance
MMA demonstrates superior diagnostic accuracy compared to other markers:
- Area under the curve of 0.963 for detecting inadequate B12 status 5
- Optimal cutoff of >229 nmol/L for screening (Youden's index 0.80) 5
- Traditional cutoff of >376 nmol/L provides highest specificity (>99%) with reasonable sensitivity (54.9%) for low-prevalence populations 5
Important Caveats
Renal function must be normal when interpreting MMA, as impaired kidney function elevates MMA independent of B12 status 3, 2. A serum MMA >280 nmol/L suggests suboptimal B12 status in young patients with normal renal function 2.
Alternative Confirmatory Marker
Homocysteine >20 µmol/L may also suggest B12 deficiency in folate-replete patients, though it's less specific than MMA (area under curve 0.937 vs 0.963) 2, 5. Homocysteine can be elevated in folate deficiency, renal disease, and other conditions, making it a less reliable standalone marker.